Diuretics and renal cell carcinoma—What is the risk/benefit ratio?
- 1 October 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (4), 1603-1604
- https://doi.org/10.1046/j.1523-1755.1999.00713-3.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hypertension, Antihypertensive Medication Use, and Risk of Renal Cell CarcinomaAmerican Journal of Epidemiology, 1999
- Sex differences in antihypertensive drug useJournal Of Hypertension, 1998
- Renal cell carcinomaCurrent Opinion in Oncology, 1998
- Estradiol enhances thiazide-sensitive NaCl cotransporter density in the apical plasma membrane of the distal convoluted tubule in ovariectomized rats.Journal of Clinical Investigation, 1998
- International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertensionInternational Journal of Cancer, 1995
- Use of Diuretics and Other Antihypertensive Medications in Relation to the Risk of Renal Cell CancerAmerican Journal of Epidemiology, 1994
- Risk Factors for Renal Cell Carcinoma in Denmark: Role of Medication and Medical HistoryInternational Journal of Epidemiology, 1994
- Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factorsCancer Causes & Control, 1992
- Severe Diuretic-Induced Hyponatremia in the ElderlyArchives of Internal Medicine, 1986
- N-Nitroso derivatives of hydrochlorothiazide, niridazole, and tolbutamideToxicology and Applied Pharmacology, 1977